Archives: Publications

• Hyassat D, Al-Refai A, Khader YS, Juweid ME, AlSharaydeh S, Layyous N, Aljabiry H, AlDurgham A, Baqain LZ, Abu Summaqa J, Al-Shimi R, Atieh FM, Mahasneh A, Alaraj S, Al-Wakfi A, Mahafza O, El-Khateeb M, Ajlouni K. Metabolic syndrome among patients with type 2 diabetes in Jordan: A cross-sectional study Medicine (Baltimore)

• Abdel Rahman A, Kassem NOF, Edwards MLE, Abdallah B, Abdel Malak R. Adding sugar to children’s beverages: a theory of planned behavior study of Lebanese mothers Health Promot Int

• Zhou XD, Chen QF, Targher G, Byrne CD, Mantzoros CS, Zhang H, Lonardo A, Lip GYH, Porta G, Misra A, Robertson AG, Luo F, Alisi A, Yang W, El-Shabrawi M, Al Momani H, Somers VK, Katsouras CS, Méndez-Sánchez N, Lefere S, Szepietowski O, Sung KC, Hui Ng NB, Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021 Clin Nutr

• Coral DE, Smit F, Farzaneh A, Gieswinkel A, Tajes JF, Sparsø T, Delfin C, Bauvin P, Wang K, Temprosa M, De Cock D, Blanch J, Fernández-Real JM, Ramos R, Ikram MK, Gomez MF, Kavousi M, Panova-Noeva M, Wild PS, van der Kallen C, Adriaens M, van Greevenbroek Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases Nat Med

  Insulin Resistance & Diabetes

• McDonnell Murray R, Peelo C, Duffy F. Navigating the food environment: Experiences of reduced calorie interventions to manage Type 2 Diabetes Mellitus J Health Psychol

• Siriyotha S, Anothaisintawee T, Looareesuwan P, Nimitphong H, McKay GJ, Attia J, Thakkinstian A. Effectiveness of glucagon-like peptide-1 receptor agonists for reduction of body mass index and blood glucose control in patients with type 2 diabetes mellitus and obesity: A retrospective cohort study and difference-in-difference analysis BMJ Open

• Bitterlich LM, Tunstead C, Hogan AE, Ankrum JA, English K. Mesenchymal stromal cells can block palmitate training of macrophages via cyclooxygenase-2 and interleukin-1 receptor antagonist Cytotherapy

• le Roux CW, Steen O, Lucas KJ, Ekinci EI, Startseva E, Unseld A, Hussain SA, Hennige AM. Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial Diabetes Obes Metab

  Insulin Resistance & Diabetes

• Cohen RV, Park JY, Prager G, Bueter M, le Roux CW, Parmar C, Kermansaravi M, Salminen P, Miras AD. Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review Br J Surg

• Cohen RV, Busetto L, Levinson R, Le Roux CW, Salminen P, Prager G; International Consensus on the Role of Obesity Management Medications in the Context of Metabolic Bariatric Surgery. International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Br J Surg